483 results on '"Sanz, Guillermo F."'
Search Results
2. Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
3. Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
4. The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes
5. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies
6. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
7. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
8. Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia
9. Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation
10. Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors
11. Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7
12. Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: randomized phase 3 ASTRAL-2 trial
13. MDS-476 Sabatolimab (MBG453) Combination Treatment Regimens for Patients With Higher-Risk Myelodysplastic Syndromes (HR-MDS): The Myelodysplastic Syndromes Studies in the STIMULUS Immuno-Myeloid Clinical Trial Program
14. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis
15. Single or Double Cord Blood Unit for Transplant: What Have We Learned?
16. Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia
17. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes
18. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
19. Killer Cell Immunoglobulin-Like Receptor–Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia
20. Current management of patients with chronic myelomonocytic leukemia
21. An Agenda to Advance Research in Myelodysplastic Syndromes: A TOP 10 Priority List From the First International Workshop in MDS
22. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
23. STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2
24. Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes
25. Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen
26. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
27. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
28. Effect of CD8+ Cell Content on Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies
29. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy
30. Impact on Outcomes of Human Leukocyte Antigen Matching by Allele-Level Typing in Adults with Acute Myeloid Leukemia Undergoing Umbilical Cord Blood Transplantation
31. An agenda to advance research in MDS: A TOP 10 Priority List from the first international workshop in MDS (iwMDS)
32. Poster: MDS-476 Sabatolimab (MBG453) Combination Treatment Regimens for Patients With Higher-Risk Myelodysplastic Syndromes (HR-MDS): The Myelodysplastic Syndromes Studies in the STIMULUS Immuno-Myeloid Clinical Trial Program
33. Myeloablative Cord Blood Transplantation in Adults with Acute Leukemia: Comparison of Two Different Transplant Platforms
34. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
35. Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation
36. Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group
37. Significance of Increased Blastic-Appearing Cells in Bone Marrow Following Myeloablative Unrelated Cord Blood Transplantation in Adult Patients
38. Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis
39. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas
40. Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts
41. Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients
42. Umbilical cord blood transplantation from unrelated donors in adult patients with chronic myeloid leukaemia
43. Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia
44. Single-Unit Umbilical Cord Blood Transplantation from Unrelated Donors in Adult Patients with Chronic Myelogenous Leukemia
45. Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation
46. Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival
47. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia
48. One-Unit versus Two-Unit Cord-Blood Transplantation
49. Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents
50. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.